Yes, this is real. VA published an interim final rule on February 17, 2026 called "Evaluative Rating: Impact of Medication," which would have changed how medication side effects or medication needs factor into disability rating evaluations. Just ten days later, on February 27, 2026, VA reversed course. The Federal Register notice states VA "is rescinding the interim final rule, Evaluative Rating: Impact of Medication, published on February 17, 2026, and restoring the prior regulatory text."
In plain terms, the brief rule change is gone. The regulations governing how medication impact is treated in evaluative ratings go back to whatever text existed before February 17, 2026 — the interim rule never got a chance to become permanent policy.
Official 2026 VA monthly compensation, including the 2.8% COLA increase.
Dependent add-ons start at a 30% rating. Child-only and dependent-parent rates: see the full 2026 pay chart.
| Rating | Monthly (2026, incl. 2.8% COLA) |
|---|---|
| 10% | $180.42 |
| 20% | $356.66 |
| 30% | $552.47 |
| 40% | $795.84 |
| 50% | $1,132.90 |
| 60% | $1,435.02 |
| 70% | $1,808.45 |
| 80% | $2,102.15 |
| 90% | $2,362.30 |
| 100% | $3,938.58 |
Does your rating decision hold up under a real audit?
Upload your decision letter and C&P exams — VetAid's analyzer reads the full file, checks every examiner statement word-for-word against your records, and shows which arguments for a higher rating actually hold. Free, and we never take a cut of your back pay.
Analyze my claim free →The notice also says "this rescission is effective immediately upon publication," meaning the rollback took effect the moment it was published on February 27, 2026. There is no delay or grace period mentioned.
The source text does not say whether the ten-day window (February 17–27, 2026) when the interim rule was technically in effect will have any retroactive impact on decisions made during that time. It also does not mention back pay, does not describe what specific rating criteria the interim rule changed, and does not say whether VA plans to issue a new rule on this topic in the future. If you filed or were rated during that short window, the rescission notice itself gives no guidance on whether your claim will be reprocessed under the restored prior rule automatically or whether you would need to request review.
Because the interim rule was so short-lived and is now void, veterans should generally expect their claims to be evaluated under the same medication-impact standards that applied before February 17, 2026 — essentially, nothing has changed from a veteran's day-to-day perspective compared to before this whole episode.
If you have a pending claim, check whether any decision, exam, or rating narrative dated between February 17 and February 27, 2026 references the now-rescinded rule, and if so, contact VA or file a supplemental claim or request review to ensure your evaluation is based on the restored prior regulatory text rather than the brief interim rule.
Need a deeper analysis?
Our AI checks your situation against outcome data from 1,900,000+ Board of Veterans' Appeals (BVA) decisions (1993–2025).
Analyze Your Claim Free